Retatrutide
Reta; LY3437943; Triple G; GGG tri-agonist
GLP-164 vendors ยท 400 listings
Size
52 more at 10mg
Retatrutide Prices
Also known as Reta; LY3437943; Triple G; GGG tri-agonist
400 listings from 64 vendors, normalised to one honest price per milligram.
Cheapest per mg
$2.00/mg
At
Southern Aminos
Vendors
64
Sizes
2mg, 5mg, 5mg Kit (3 vials), 5mg Kit (10 vials), 5mg Kit (5 vials), 5mg Kit (2 vials), 6mg, 6mg Kit (10 vials), 7mg, 8mg, 10mg, 10mg Kit (10 vials), 10mg Kit (2 vials), 10mg Kit (5 vials), 10mg Kit (3 vials), 12mg, 12mg Kit (10 vials), 15mg Kit (10 vials), 15mg, 15mg Kit (5 vials), 15mg Kit (3 vials), 16mg, 18mg, 20mg, 20mg Kit (10 vials), 20mg Kit (5 vials), 20mg Kit (3 vials), 20mg Kit (2 vials), 24mg, 24mg Kit (10 vials), 26mg, 30mg, 30mg Kit (10 vials), 30mg Kit (5 vials), 30mg Kit (3 vials), 36mg, 40mg, 40mg Kit (10 vials), 40mg Kit (2 vials), 40mg Kit (5 vials), 40mg Kit (3 vials), 48mg, 48mg Kit (10 vials), 50mg, 50mg Kit (10 vials), 50mg Kit (5 vials), 50mg Kit (3 vials), 60mg, 60mg Kit (10 vials), 60mg Kit (5 vials), 60mg Kit (3 vials), 100mg, 100mg Kit (5 vials), 100mg Kit (10 vials), 120mg, 120mg Kit (10 vials), 200mg Kit (10 vials), 240mg, 480mg
Retatrutide price per mg by vendor
Prices last collected October 3, 2026. Prices change often - check the vendor's site before ordering.
Choose a size to compare vendor prices.
Mixing Retatrutide
What each amount of water produces at this vial size. Educational reference, not a recommendation.
1 mL5.00 mg/mL2 mg = 40 units
0.5 mL10.00 mg/mL2 mg = 20 units
0.75 mL6.67 mg/mL2 mg = 30 units
Vial sizes are the ones vendors list for Retatrutide. Syringe marks assume a 2 mg dose on a U-100 syringe, taken from this compound's reference range. Work out any other combination in the reconstitution calculator.
About Retatrutide
- What it is
- Retatrutide is an investigational peptide that activates three metabolic hormone receptors at once, namely GIP, GLP-1, and glucagon. By engaging all three it increases insulin release, curbs appetite, and raises energy expenditure, producing large reductions in body weight and liver fat in trials. It is not approved for any use and is being studied mainly for obesity and fatty liver disease.
- How it works
- It activates the GIP, GLP-1, and glucagon receptors together to reduce appetite, improve insulin response, and raise energy expenditure.
- Researched for
- Obesity research; fatty liver disease; type 2 diabetes; metabolic disease
- Half-life
- Approximately 6 days
- Familiarity
- Advanced
- Research evidence
- Human trials - phase 2 or 3
- Regulatory status
- Phase 3
- Key risk
- No approved label or boxed warning yet; the GLP-1 receptor agonist class carries a documented rodent thyroid C-cell tumor signal.
Disclosure. Some vendors above are Peptul partners and pay us a commission when you buy through our link. Rows are ordered by: Peptul partners first, then what is in stock, then single vials before multi-vial packs, then price per milligram. Paying us moves a vendor up this order and changes nothing else - not their trust tier, COA badge, Peptul Score or reviews, which come from evidence and are worked out the same way for everyone. Available discount codes are shown beside the prices above. Discounted prices require the displayed code where indicated.
For educational and research purposes only. Not medical advice. Always consult a qualified healthcare provider before using any research compound.